Xcout IntelSign inSubscribe

NephroDI Therapeutics, Inc.

BiotechnologySeattle, WA, United States

NephroDI Therapeutics, Inc. is a clinical-stage pharmaceutical and biotechnology company focused on developing specialized therapeutics. The company is headquartered in Seattle, Washington, United States.

Subscribe to see NephroDI Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

NephroDI Therapeutics, Inc. at a glance

NephroDI Therapeutics, Inc. is a biotechnology company headquartered in Seattle, United States. It has raised at least $3.6M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $2M in June 2024. Xcout tracks 7 named people at NephroDI Therapeutics, Inc., including Rachael Hagan (President).

As of 17 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Seattle, WA, United States
Raised, rounds on record
$3.6M

NephroDI Therapeutics, Inc. leadership

  • Rachael HaganPresident
  • Jeff SandsChief Medical Officer
  • Janet Kleinco-founder and Director of Biology
  • Dennis “Mike” RoseVP of Operations
  • Mike RoseVP of Operations
  • Janet KleinDirector of Biology

1 more named person on record for NephroDI Therapeutics, Inc., with roles, board committees and tenure — see the full roster →

NephroDI Therapeutics, Inc. funding rounds

At least $3.6M raised across the 2 rounds on record. Every round on record:

DateRoundAmountInvestors
Series A$2M2 named
SEC Form D filing$1.6M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

NephroDI Therapeutics, Inc. competitors

A few of NephroDI Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →

Get NephroDI Therapeutics, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about NephroDI Therapeutics, Inc.? Suggest a correction · Work at NephroDI Therapeutics, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

NephroDI Therapeutics, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

NephroDI Therapeutics, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on NephroDI Therapeutics, Inc. in Xcout Intel

  • 7 named people with titles, LinkedIn and board committees
  • 2 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →